240 related articles for article (PubMed ID: 15111120)
1. Cytochrome b5 oxidoreductase: expression and characterization of the original familial ideopathic methemoglobinemia mutations E255- and G291D.
Davis CA; Barber MJ
Arch Biochem Biophys; 2004 May; 425(2):123-32. PubMed ID: 15111120
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome b5 reductase: the roles of the recessive congenital methemoglobinemia mutants P144L, L148P, and R159*.
Davis CA; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2004 Nov; 431(2):233-44. PubMed ID: 15488472
[TBL] [Abstract][Full Text] [Related]
3. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
Roma GW; Crowley LJ; Barber MJ
Arch Biochem Biophys; 2006 Aug; 452(1):69-82. PubMed ID: 16814740
[TBL] [Abstract][Full Text] [Related]
4. Recessive congenital methaemoglobinaemia: functional characterization of the novel D239G mutation in the NADH-binding lobe of cytochrome b5 reductase.
Percy MJ; Crowley LJ; Davis CA; McMullin MF; Savage G; Hughes J; McMahon C; Quinn RJ; Smith O; Barber MJ; Lappin TR
Br J Haematol; 2005 Jun; 129(6):847-53. PubMed ID: 15953014
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome b5 reductase: role of the si-face residues, proline 92 and tyrosine 93, in structure and catalysis.
Marohnic CC; Crowley LJ; Davis CA; Smith ET; Barber MJ
Biochemistry; 2005 Feb; 44(7):2449-61. PubMed ID: 15709757
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of the novel FAD-binding lobe G75S mutation in cytochrome b(5) reductase: an aid to determine recessive congenital methemoglobinemia status in an infant.
Percy MJ; Crowley LJ; Roper D; Vulliamy TJ; Layton DM; Barber MJ
Blood Cells Mol Dis; 2006; 36(1):81-90. PubMed ID: 16310381
[TBL] [Abstract][Full Text] [Related]
7. Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase.
Roma GW; Crowley LJ; Davis CA; Barber MJ
Biochemistry; 2005 Oct; 44(41):13467-76. PubMed ID: 16216070
[TBL] [Abstract][Full Text] [Related]
8. The structure of the S127P mutant of cytochrome b5 reductase that causes methemoglobinemia shows the AMP moiety of the flavin occupying the substrate binding site.
Bewley MC; Davis CA; Marohnic CC; Taormina D; Barber MJ
Biochemistry; 2003 Nov; 42(45):13145-51. PubMed ID: 14609324
[TBL] [Abstract][Full Text] [Related]
9. Thiol modification and site directed mutagenesis of the flavin domain of spinach NADH:nitrate reductase.
Trimboli AJ; Quinn GB; Smith ET; Barber MJ
Arch Biochem Biophys; 1996 Jul; 331(1):117-26. PubMed ID: 8660690
[TBL] [Abstract][Full Text] [Related]
10. Expression of a novel P275L variant of NADH:cytochrome b5 reductase gives functional insight into the conserved motif important for pyridine nucleotide binding.
Percy MJ; Crowley LJ; Boudreaux J; Barber MJ
Arch Biochem Biophys; 2006 Mar; 447(1):59-67. PubMed ID: 16469290
[TBL] [Abstract][Full Text] [Related]
11. Arginine 91 is not essential for flavin incorporation in hepatic cytochrome b(5) reductase.
Marohnic CC; Barber MJ
Arch Biochem Biophys; 2001 May; 389(2):223-33. PubMed ID: 11339812
[TBL] [Abstract][Full Text] [Related]
12. A novel G143D mutation in the NADH-cytochrome b5 reductase gene in an Indian patient with type I recessive hereditary methemoglobinemia.
Kedar PS; Warang P; Nadkarni AH; Colah RB; Ghosh K
Blood Cells Mol Dis; 2008; 40(3):323-7. PubMed ID: 17964195
[TBL] [Abstract][Full Text] [Related]
13. Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene.
Fermo E; Bianchi P; Vercellati C; Marcello AP; Garatti M; Marangoni O; Barcellini W; Zanella A
Blood Cells Mol Dis; 2008; 41(1):50-5. PubMed ID: 18343696
[TBL] [Abstract][Full Text] [Related]
14. Engineering and characterization of a NADPH-utilizing cytochrome b5 reductase.
Marohnic CC; Bewley MC; Barber MJ
Biochemistry; 2003 Sep; 42(38):11170-82. PubMed ID: 14503867
[TBL] [Abstract][Full Text] [Related]
15. Heterologous expression of an endogenous rat cytochrome b(5)/cytochrome b(5) reductase fusion protein: identification of histidines 62 and 85 as the heme axial ligands.
Davis CA; Dhawan IK; Johnson MK; Barber MJ
Arch Biochem Biophys; 2002 Apr; 400(1):63-75. PubMed ID: 11913972
[TBL] [Abstract][Full Text] [Related]
16. Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency.
Percy MJ; Lappin TR
Br J Haematol; 2008 May; 141(3):298-308. PubMed ID: 18318771
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation of the cytochrome-b5 reductase gene in an Indian patient: the molecular basis of type I methemoglobinemia.
Nussenzveig RH; Lingam HB; Gaikwad A; Zhu Q; Jing N; Prchal JT
Haematologica; 2006 Nov; 91(11):1542-5. PubMed ID: 17082011
[TBL] [Abstract][Full Text] [Related]
18. Structural and mechanistic roles of three consecutive Pro residues of porcine NADH-cytochrome b(5) reductase for the binding of beta-NADH.
Nishimura Y; Shibuya M; Muraki A; Takeuchi F; Park SY; Tsubaki M
J Biosci Bioeng; 2009 Oct; 108(4):286-92. PubMed ID: 19716516
[TBL] [Abstract][Full Text] [Related]
19. Role of carboxyl residues surrounding heme of human cytochrome b5 in the electrostatic interaction with NADH-cytochrome b5 reductase.
Kawano M; Shirabe K; Nagai T; Takeshita M
Biochem Biophys Res Commun; 1998 Apr; 245(3):666-9. PubMed ID: 9588172
[TBL] [Abstract][Full Text] [Related]
20. Structure, interaction and electron transfer between cytochrome b5, its E44A and/or E56A mutants and cytochrome c.
Sun YL; Wang YH; Yan MM; Sun BY; Xie Y; Huang ZX; Jiang SK; Wu HM
J Mol Biol; 1999 Jan; 285(1):347-59. PubMed ID: 9878411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
